Inovio Pharmaceuticals Statistics
Total Valuation
INO has a market cap or net worth of $238.38 million. The enterprise value is $123.29 million.
| Market Cap | 238.38M |
| Enterprise Value | 123.29M |
Important Dates
The next estimated earnings date is Wednesday, May 8, 2024, after market close.
| Earnings Date | May 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
INO has 23.37 million shares outstanding. The number of shares has increased by 11.51% in one year.
| Shares Outstanding | 23.37M |
| Shares Change (YoY) | +11.51% |
| Shares Change (QoQ) | +1.56% |
| Owned by Insiders (%) | 1.61% |
| Owned by Institutions (%) | 18.06% |
| Float | 22.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 286.51 |
| Forward PS | 312.40 |
| PB Ratio | 2.03 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 148.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.60, with a Debt / Equity ratio of 0.26.
| Current Ratio | 3.60 |
| Quick Ratio | 3.47 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -109.50 |
Financial Efficiency
Return on equity (ROE) is -86.60% and return on invested capital (ROIC) is -97.55%.
| Return on Equity (ROE) | -86.60% |
| Return on Assets (ROA) | -62.60% |
| Return on Capital (ROIC) | -97.55% |
| Revenue Per Employee | $6,820 |
| Profits Per Employee | -$1.11M |
| Employee Count | 122 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.56% in the last 52 weeks. The beta is 1.12, so INO's price volatility has been higher than the market average.
| Beta (1Y) | 1.12 |
| 52-Week Price Change | -3.56% |
| 50-Day Moving Average | 10.04 |
| 200-Day Moving Average | 6.71 |
| Relative Strength Index (RSI) | 44.39 |
| Average Volume (30 Days) | 497,551 |
Short Selling Information
The latest short interest is 2.10 million, so 9.00% of the outstanding shares have been sold short.
| Short Interest | 2.10M |
| Short Previous Month | 2.06M |
| Short % of Shares Out | 9.00% |
| Short % of Float | 9.14% |
| Short Ratio (days to cover) | 3.53 |
Income Statement
In the last 12 months, INO had revenue of $832,010 and -$135.12 million in losses. Loss per share was -$6.09.
| Revenue | 832,010 |
| Gross Profit | 832,010 |
| Operating Income | -143.94M |
| Pretax Income | -135.12M |
| Net Income | -135.12M |
| EBITDA | -130.39M |
| EBIT | -133.89M |
| Loss Per Share | -$6.09 |
Balance Sheet
The company has $145.29 million in cash and $30.21 million in debt, giving a net cash position of $115.08 million or $4.92 per share.
| Cash & Cash Equivalents | 145.29M |
| Total Debt | 30.21M |
| Net Cash | 115.08M |
| Net Cash Per Share | $4.92 |
| Equity / Book Value | 117.35M |
| Book Value Per Share | 5.02 |
| Working Capital | 110.54M |
Cash Flow
In the last 12 months, operating cash flow was -$124.37 million and capital expenditures $5.90 million, giving a free cash flow of -$118.47 million.
| Operating Cash Flow | -124.37M |
| Capital Expenditures | 5.90M |
| Free Cash Flow | -118.47M |
| FCF Per Share | -$5.34 |
Margins
Gross margin is 100.00%, with operating and profit margins of -17,300.28% and -16,239.87%.
| Gross Margin | 100.00% |
| Operating Margin | -17,300.28% |
| Pretax Margin | -16,239.87% |
| Profit Margin | -16,239.87% |
| EBITDA Margin | -15,671.81% |
| EBIT Margin | -16,092.90% |
| FCF Margin | -14,238.67% |
Dividends & Yields
INO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -11.51% |
| Shareholder Yield | -11.51% |
| Earnings Yield | -56.68% |
| FCF Yield | -49.70% |
Analyst Forecast
The average price target for INO is $21.00, which is 105.88% higher than the current price. The consensus rating is "Buy".
| Price Target | $21.00 |
| Price Target Difference | 105.88% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 25.84% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 25, 2024. It was a reverse split with a ratio of 1:12.
| Last Split Date | Jan 25, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
INO has an Altman Z-Score of -12.43 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.43 |
| Piotroski F-Score | 3 |